GALENICAL FORMULATIONS OF ORGANIC COMPOUNDS
The present invention relates to a pharmaceutical oral fixed dose combination comprising a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, b) a therapeutically effective amount of Valsartan, or a pharmaceutically acceptable salt thereof, wherein the p...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
09.04.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a pharmaceutical oral fixed dose combination comprising a) a therapeutically effective amount of Aliskiren, or a pharmaceutically acceptable salt thereof, b) a therapeutically effective amount of Valsartan, or a pharmaceutically acceptable salt thereof, wherein the pharmaceutical oral fixed dose combination shows an in vitro dissolution of component a) of 80% or less after 10 minutes and 98% or less after 20 minutes, and a dissolution profile of component b) of 25% or more after 30 minutes, and 40% or more after 60 minutes at pH 4.5. |
---|---|
Bibliography: | Application Number: CA20082698330 |